These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28627450)

  • 21. KRAS mutation detection and prognostic potential in sporadic colorectal cancer using high-resolution melting analysis.
    Deschoolmeester V; Boeckx C; Baay M; Weyler J; Wuyts W; Van Marck E; Peeters M; Lardon F; Vermorken JB
    Br J Cancer; 2010 Nov; 103(10):1627-36. PubMed ID: 20959826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [KRAS Genetic Mutation Analysis Using the Clinical FFPE Samples of Colorectal Carcinomas: Comparative Study among 5 Methods].
    Okada K; Asano N; Kajiura Y; Shimoyama Y; Matsumoto H; Matsushita T
    Rinsho Byori; 2015 Oct; 63(10):1144-51. PubMed ID: 26897849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitive detection of KRAS mutations in archived formalin-fixed paraffin-embedded tissue using mutant-enriched PCR and reverse-hybridization.
    Ausch C; Buxhofer-Ausch V; Oberkanins C; Holzer B; Minai-Pour M; Jahn S; Dandachi N; Zeillinger R; Kriegshäuser G
    J Mol Diagn; 2009 Nov; 11(6):508-13. PubMed ID: 19797612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-Tubed Wild-Type Blocking Quantitative PCR Detection Assay for the Sensitive Detection of Codon 12 and 13 KRAS Mutations.
    Huang JF; Zeng DZ; Duan GJ; Shi Y; Deng GH; Xia H; Xu HQ; Zhao N; Fu WL; Huang Q
    PLoS One; 2015; 10(12):e0145698. PubMed ID: 26701781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Highly Verified Assay for KRAS Mutation Detection in Tissue and Plasma of Lung, Colorectal, and Pancreatic Cancer.
    Li J; Gan S; Blair A; Min K; Rehage T; Hoeppner C; Halait H; Brophy VH
    Arch Pathol Lab Med; 2019 Feb; 143(2):183-189. PubMed ID: 30088781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extreme assay sensitivity in molecular diagnostics further unveils intratumour heterogeneity in metastatic colorectal cancer as well as artifactual low-frequency mutations in the KRAS gene.
    Mariani S; Bertero L; Osella-Abate S; Di Bello C; Francia di Celle P; Coppola V; Sapino A; Cassoni P; Marchiò C
    Br J Cancer; 2017 Jul; 117(3):358-366. PubMed ID: 28618430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymmetric mutant-enriched polymerase chain reaction and quantitative DNA melting analysis of KRAS mutation in colorectal cancer.
    Botezatu IV; Kondratova VN; Shelepov VP; Mazurenko NN; Tsyganova IV; Susova OY; Lichtenstein AV
    Anal Biochem; 2020 Feb; 590():113517. PubMed ID: 31782995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mutation scanning of short amplicons: optimization of DNA melting conditions].
    Botezatu IV; Zhordania KI; Karseladze AI; Stroganova AM; Kondratova BN; Shelepov VP; Telkov MV; Likhtenshtein AV
    Mol Biol (Mosk); 2012; 46(3):461-8. PubMed ID: 22888635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors affecting KRAS mutation detection in colorectal cancer tissue.
    Yun HG; Lee HJ; Kim BR; Lee JH; Lee JH; Lee MY; Kim DH; Sohn JH; Chae SW; Do IG; Do SI; Kim K
    Pathol Res Pract; 2019 May; 215(5):1071-1075. PubMed ID: 30846412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-time PCR-based method for the rapid detection of extended RAS mutations using bridged nucleic acids in colorectal cancer.
    Iida T; Mizuno Y; Kaizaki Y
    Clin Chim Acta; 2019 Feb; 489():164-168. PubMed ID: 29111094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quick-multiplex-consensus (QMC)-PCR followed by high-resolution melting: a simple and robust method for mutation detection in formalin-fixed paraffin-embedded tissue.
    Fadhil W; Ibrahem S; Seth R; Ilyas M
    J Clin Pathol; 2010 Feb; 63(2):134-40. PubMed ID: 20154035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer.
    Xu JM; Liu XJ; Ge FJ; Lin L; Wang Y; Sharma MR; Liu ZY; Tommasi S; Paradiso A
    J Exp Clin Cancer Res; 2014 Dec; 33(1):104. PubMed ID: 25491325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Awareness of mutational artefacts in suboptimal DNA samples: possible risk for therapeutic choices.
    Mariani S; Bertero L; Coppola V; Saracco G; Arezzo A; Francia Di Celle P; Metovic J; Marchiò C; Cassoni P
    Expert Rev Mol Diagn; 2018 May; 18(5):467-475. PubMed ID: 29676606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials.
    Peeters M; Kafatos G; Taylor A; Gastanaga VM; Oliner KS; Hechmati G; Terwey JH; van Krieken JH
    Eur J Cancer; 2015 Sep; 51(13):1704-13. PubMed ID: 26049686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing.
    Sakai K; Tsurutani J; Yamanaka T; Yoneshige A; Ito A; Togashi Y; De Velasco MA; Terashima M; Fujita Y; Tomida S; Tamura T; Nakagawa K; Nishio K
    PLoS One; 2015; 10(5):e0121891. PubMed ID: 25954997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
    Zhang X; Wang Y; Gao N; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform.
    Darwanto A; Hein AM; Strauss S; Kong Y; Sheridan A; Richards D; Lader E; Ngowe M; Pelletier T; Adams D; Ricker A; Patel N; Kühne A; Hughes S; Shiffman D; Zimmermann D; Te Kaat K; Rothmann T
    BMC Cancer; 2017 May; 17(1):358. PubMed ID: 28532404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of real-time PCR-optimized oligonucleotide probe method and Sanger sequencing for detection of KRAS mutations in colorectal and lung carcinomas].
    Qiu T; Ling Y; Chen Z; Shan L; Guo L; Lü N; Ying JM
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):599-602. PubMed ID: 23157827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High sensitive mutation analysis on KRAS gene using LNA/DNA chimeras as PCR amplification blockers of wild-type alleles.
    Huang Q; Wang GY; Huang JF; Zhang B; Fu WL
    Mol Cell Probes; 2010 Dec; 24(6):376-80. PubMed ID: 20732413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of KRAS mutations in colorectal carcinoma patients with an integrated PCR/sequencing and real-time PCR approach.
    Carotenuto P; Roma C; Rachiglio AM; Tatangelo F; Pinto C; Ciardiello F; Nappi O; Iaffaioli RV; Botti G; Normanno N
    Pharmacogenomics; 2010 Aug; 11(8):1169-79. PubMed ID: 20712532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.